The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells

Histochemistry and Cell Biology

Volumn 114, Issue 1, 2000, Pages 1-7

  Kofler, R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

CCRF CEM; DNA chip analysis; Glucocorticoid induced apoptosis; Lymphatic leukemia; Pathophysiology

Indexed keywords

CASPASE; DRUG RECEPTOR; GLUCOCORTICOID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; DRUG MECHANISM; GENE CONTROL; HUMAN; LEUKEMIA CELL LINE; LYMPHATIC LEUKEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033868781     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004180000165     Document Type: Review

References (75)

1. Alnemri ES, Fernandes TF, Haldar S, Croce CM, Litwack G (1992) Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res 52:491-495
2. Amarante-Mendes GP, Finucane DM, Martin SJ, Cotter TG, Salvesen GS, Green DR (1998) Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Differ 5:298-306
3. Antakly T, Thompson EB, O'Donnell D (1989) Demonstration of the intracellular location and up-regulation of glucocorticoid receptor by in situ hybridization and immunocytochemistry. Cancer Res 49:2230s-2234s
4. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305-1308
5. Ashraf J, Thompson EB (1993) Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes. Mol Endocrinol 7:631-642
6. Ausserlechner MJ (2000) Mechanisms of p16/INK4A- and glucocorticoid-induced cell cycle arrest and its role for induction of apoptosis and differentiation in human leukemic cells. PhD Thesis, University of Innsbruck, Faculty of Natural Sciences
7. Baughman G, Harrigan MT, Campbell NF, Nurrish SJ, Bourgeois S (1991) Genes newly identified as regulated by glucocorticoids in murine thymocytes. Mol Endocrinol 5:637-644
8. Benson RSP, Dive C, Watson AJM (1998) Comparative effects of Bcl-2 over-expression and ZVAD.FMK treatment on dexamethasone and VP16-induced apoptosis in CEM cells. Cell Death Differ 5:432-439
9. Briehl MM, Flomerfelt FA, Wu X-P, Miesfeld RL (1990) Transcriptional analyses of steroid-regulated gene networks. Mol Endocrinol 4:287-294
10. Brunet CL, Gunby RH, Benson RSP, Hickman JA, Watson AJM, Brady G (1998) Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ 5:107-115
11. Chandra J, Gilbreath J, Freireich EJ, Kliche KO, Andreeff M, Keating M, McConkey DJ (1997) Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood 90:3673-3681
12. Chapman MS, Qu N, Pascoe S, Chen WX, Apostol C, Gordon D, Miesfeld RL (1995) Isolation of differentially expressed sequence tags from steroid-responsive cells using mRNA differential display. Mol Cell Endocrinol 108:R1-R7
13. Chen F, Watson CS, Gametchu B (1999) Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells. J Cell Biochem 74:418-429
14. Cheng J, Haas M (1990) Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 10:5502-5509
15. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852
16. Cohen JJ (1992) Glucocorticoid-induced apoptosis in the thymus. Semin Immunol 4:363-369
17. Cory S (1995) Regulation of lymphocyte survival by the BCL-2 gene family. Annu Rev Immunol 13:513-543
18. Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24:68-72
19. Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S, Gadner H, Riehm H, Schrappe M (1999) Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 94:1209-1217
20. Ekert PG, Silke J, Vaux DL (1999) Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: optimal caspase substrates are not necessarily optimal inhibitors. EMBO J 18:330-338
21. Evan GI, Littlewood T (1998) A matter of life and cell death. Science 281:1317-1322
22. Evans-Storms RB, Cidlowski JA (1995) Regulation of apoptosis by steroid hormones. J Steroid Biochem Mol Biol 53:1-8
23. Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS (1999) Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 93:3044-3052
24. Friesen C, Herr I, Krammer PH, Debatin KM (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574-577
25. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA (1998) Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 273:32608-32613
26. Gearing KL, Cairns W, Okret S, Gustafsson J-Å (1993) Heterogeneity in the 5′ untranslated region of the rat glucocorticoid receptor mRNA. J Steroid Biochem Mol Biol 46:635-639
27. Geley S, Fiegl M, Hartmann BL, Kofler R (1996a) Genes mediating glucocorticoid effects and mechanisms of their regulation. Rev Physiol Biochem Pharmacol 128:1-97
28. Geley S, Hartmann BL, Hala M, Strasser-Wozak EMC, Kapelari K, Kofler R (1996b) Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression. Cancer Res 56:5033-5038
29. Geley S, Hartmann BL, Kapelari K, Egle A, Villunger A, Heidacher D, Greil R, Auer B, Kofler R (1997a) The interleukin 1b-converting enzyme inhibitor crmA prevents Apo1/fas-but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells. FEBS Lett 402:36-40
30. Geley S, Hartmann BL, Hattmannstorfer R, Löffler M, Ausserlechner MJ, Bernhard D, Sgonc R, Strasser-Wozak EMC, Ebner M, Auer B, Kofler R (1997b) P53-induced apoptosis in the human T-ALL cell line CCRF-CEM. Oncogene 15:2429-2437
31. Gomi M, Moriwaki K, Katagiri S, Kurata Y, Thompson EB (1990) Glucocorticoid effects on myeloma cells in culture: correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA. Cancer Res 50:1873-1878
32. Green DR (1998) Apoptotic pathways: the roads to ruin. Cell 94:695-698
33. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309-1312
34. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, De la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM, Mak TW (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94:339-352
35. Hala M, Hartmann BL, Böck G, Geley S, Koller R (1996) Glucocorticoid receptor gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines. Int J Cancer 68:663-668
36. Hartmann BL, Geley S, Löffler M, Hattmannstorfer R, Strasser-Wozak EMC, Auer B, Kofler R (1999) Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis. Oncogene 18:713-719
37. Hatz HJ (1998) Glucocortocoide. Immunologische Grundlagen, Pharmakologie und Therapierichtlinien. Wissenschaftliche, Stuttgart
38. Helmberg A, Fässler R, Geley S, Jöhrer K, Kroemer G, Böck G, Kofler R (1990) Glucocorticoid-regulated gene expression in the immune system: analysis of glucocorticoid-regulated transcripts from the mouse macrophage-like cell line P388D1. J Immunol 145:4332-4337
39. Helmberg A, Auphan N, Caelles C, Karin M (1995) Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 14:452-460
40. Horvitz HR, Shaham S, Hengartner MO (1994) The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol 59:377-385
41. Huang DC, Hahne M, Schroeter M, Frei K, Fontana A, Villunger A, Newton K, Tschopp J, Strasser A (1999) Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci USA 96:14871-14876
42. Jondal M, Xue Y, McConkey DJ, Okret S (1995) Thymocyte apoptosis by glucocorticoids and cAMP. Curr Top Microbiol Immunol 200:67-79
43. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136
44. Krammer PH (1999) CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol 71:163-210
45. Kroemer G, Petit P, Zamzami N, Vayssière JL, Mignotte B (1995) The biochemistry of programmed cell death. FASEB J 9:1277-1287
46. Kroemer G, Dallaporta B, Resche-Rigon M (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619-642
47. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang XD (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489
48. Löffler M, Tonko M, Hartmann BL, Bernhard D, Geley S, Helmberg A, Kofler R (1999) c-myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts. Oncogene 18:4626-4631
49. Longthorne VL, Williams GT (1997) Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J 16:3805-3812
50. Ma T, Mahajan PB, Thompson EA (1992) Glucocorticoid regulation of c-myc promoter utilization in P1798 T-lymphoma cells. Mol Endocrinol 6:960-968
51. L forms an ion channel in synthetic lipid membranes. Nature 385:353-357
52. Miyashita T, Nagao K, Krajewski S, Salvesen GS, Reed JC, Inoue T, Yamada M (1998) Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3. Cell Death Differ 5:1034-1041
53. Nagata S (1997) Apoptosis by death factor. Cell 88:355-365
54. Nicholson DW (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6:1028-1042
55. Oltvai ZN, Korsmeyer SJ (1994) Checkpoints of dueling dimers foil death wishes. Cell 79:189-192
56. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res 55:1436-1440
57. Parry D, Mahony D, Wills K, Lees E (1999) Cyclin D-CDK sub-unit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 19:1775-1783
58. Powers JH, Hillmann AG, Tang DC, Harmon JM (1993) Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells. Cancer Res 53:4059-4065
59. Ramdas J, Liu W, Harmon JM (1999) Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. Cancer Res 59:1378-1385
60. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schütz G (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531-541
61. Reisman D, Thompson EA (1995) Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells. Mol Endocrinol 9:1500-1509
62. Rogatsky I, Trowbridge JM, Garabedian MJ (1997) Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol 17:3181-3193
63. Schmidt TJ, Meyer AS (1994) Autoregulation of corticosteroid receptors. How, when, where, and why? Receptor 4:229-257
64. Selye H (1936) Thymus and adrenals in the response of the organism to injuries and intoxicants. Br J Exp Pathol 17:234-248
65. Strähle U, Schmidt A, Kelsey G, Stewart AF, Cole TJ, Schmid W, Schütz G (1992) At least three promoters direct expression of the mouse glucocorticoid receptor gene. Proc Natl Acad Sci USA 89:6731-6735
66. Strasser-Wozak EMC, Hattmannstorfer R, Hála M, Hartmann BL, Fiegl M, Geley S, Kofler R (1995) Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res 55:348-353
67. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184:1331-1341
68. Thompson EB (1998) Special topic: apoptosis. Annu Rev Physiol 60:525-532
69. Thulasi R, Harbour DV, Thompson EB (1993) Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. J Biol Chem 268:18306-18312
70. Tronche F, Kellendonk C, Reichardt HM, Schutz G (1998) Genetic dissection of glucocorticoid receptor function in mice. Curr Opin Genet Dev 8:532-538
71. Urashima M, Teoh G, Chauhan D, Hoshi Y, Ogata A, Treon SP, Schlossman RL, Anderson KC (1997) Interleukin-6 overcomes p21/WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-gamma in multiple myeloma cells. Blood 90:279-289
72. Vacchio MS, King LB, Ashwell JD (1996) Regulation of thymocyte development by glucocorticoids. Behring Inst Mitt 97:24-31
73. Warburg O (1929) Ist die aerobe Glycolyse spezifisch für die Tumoren? Biochem Z 204:482-487
74. Wyllie AH, Kerr JFR, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251-307
75. Yuh Y-S, Thompson EB (1989) Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone. J Biol Chem 264:10904-10910